Secondary amyloidosis associated with giant cell arteritis/polymyalgia rheumatica

被引：0
作者：
Stebbing, J
Buetens, O
Hellmann, D
Stone, J
机构：
[1] Johns Hopkins Univ, Dept Med, Baltimore, MD USA
[2] Johns Hopkins Univ, Div Rheumatol, Baltimore, MD USA
来源：
JOURNAL OF RHEUMATOLOGY | 1999年 / 26卷 / 12期
关键词：
giant cell arteritis; polymyalgia rheumatica; secondary amyloidosis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Although giant cell arteritis (GCA) is characterized by chronic inflammation, secondary (AA) amyloidosis appears to be an exceptionally rare complication of this disorder. We describe an 84-year-old man with biopsy proven GCA and polymyalgia rheumatica (PMR) who was found at autopsy to have AA amyloid deposition in numerous organs, 9 years after his diagnosis of GCA. Persistent musculoskeletal symptoms, attributed to refractory PMR during the patient's life, were likely due to AA amyloidosis. This unrecognized complication of GCA/PMR confounded his therapy, leading to excessive treatment with corticosteroids and methotrexate. This case shows that the occurrence of AA amyloidosis should be considered in patients with "refractory PMR" developing after a period of treatment, and that autopsies play a vital role in enigmatic cases.
引用
收藏
页码：2698 / 2700
页数：3
相关论文
共 50 条
[11]   Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica [J].
El Chami, Sarah ;
Springer, Jason M. .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2022, 48 (02) :493-506
[12]   Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis [J].
Matteson, Eric L. ;
Buttgereit, Frank ;
Dejaco, Christian ;
Dasgupta, Bhaskar .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2016, 42 (01) :75-+
[13]   Genetic epidemiology: Giant cell arteritis and polymyalgia rheumatica [J].
Miguel A Gonzalez-Gay .
Arthritis Research & Therapy, 3
[14]   Differential Diagnosis of Polymyalgia Rheumatica and Giant Cell Arteritis [J].
Keysser, G. .
AKTUELLE RHEUMATOLOGIE, 2014, 39 (04) :227-231
[15]   Giant cell arteritis and polymyalgia rheumatica: Diagnostic criteria [J].
Marie, I. .
REVUE DE MEDECINE INTERNE, 2013, 34 (07) :403-411
[16]   Are polymyalgia rheumatica and giant cell arteritis the same disease? [J].
Cantini, F ;
Niccoli, L ;
Storri, L ;
Nannini, C ;
Olivieri, I ;
Padula, A ;
Boiardi, L ;
Salvarani, C .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2004, 33 (05) :294-301
[17]   Discontinuation of therapies in polymyalgia rheumatica and giant cell arteritis [J].
Muratore, F. ;
Pipitone, N. ;
Hunder, G. G. ;
Salvarani, C. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (04) :S86-S92
[18]   The role of senescence in polymyalgia rheumatica and giant cell arteritis [J].
Alegria, Guillermo Carvajal .
JOINT BONE SPINE, 2025, 92 (05)
[19]   Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica [J].
van der Geest, Kornelis S. M. ;
Abdulahad, Wayel H. ;
Rutgers, Abraham ;
Horst, Gerda ;
Bijzet, Johan ;
Arends, Suzanne ;
Roffel, Mirjam P. ;
Boots, Annemieke M. H. ;
Brouwer, Elisabeth .
RHEUMATOLOGY, 2015, 54 (08) :1397-1402
[20]   Current understanding and management of giant cell arteritis and polymyalgia rheumatica [J].
Ghosh, Parasar ;
Borg, Frances A. ;
Dasgupta, Bhaskar .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (06) :913-928
12345